
|Videos|March 3, 2023
A Medical Oncologist’s Recommended Interventions For CV Risk Mitigation
Urologist David Morris, MD, FACS, shares his perspective on communicating cardiovascular risk to patients starting androgen deprivation therapy.
Advertisement
Episodes in this series

January 2023 AbbVie Inc. Company Confidential
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Kathryn Gessner, MD, PhD, on the challenges of selecting patients for bladder preservation
2
Study shows durable 3-year outcomes with first-line gemcitabine/docetaxel in NMIBC
3
First-in-human bladder transplant demonstrates sustained function at 6 months
4
Phase 3 trial launches of CAIX-targeted radiopharmaceutical for ccRCC
5



















